_version_ 1783415667502874624
author Martin-Loeches, Ignacio
Lemiale, Virginie
Geoghegan, Pierce
McMahon, Mary Aisling
Pickkers, Peter
Soares, Marcio
Perner, Anders
Meyhoff, Tine Sylvest
Bukan, Ramin Brandt
Rello, Jordi
Bauer, Philippe R.
van de Louw, Andry
Taccone, Fabio Silvio
Salluh, Jorge
Hemelaar, Pleun
Schellongowski, Peter
Rusinova, Katerina
Terzi, Nicolas
Mehta, Sangeeta
Antonelli, Massimo
Kouatchet, Achille
Klepstad, Pål
Valkonen, Miia
Landburg, Precious Pearl
Barratt-Due, Andreas
Bruneel, Fabrice
Pène, Frédéric
Metaxa, Victoria
Moreau, Anne Sophie
Souppart, Virginie
Burghi, Gaston
Girault, Christophe
Silva, Ulysses V. A.
Montini, Luca
Barbier, Francois
Nielsen, Lene B.
Gaborit, Benjamin
Mokart, Djamel
Chevret, Sylvie
Azoulay, Elie
author_facet Martin-Loeches, Ignacio
Lemiale, Virginie
Geoghegan, Pierce
McMahon, Mary Aisling
Pickkers, Peter
Soares, Marcio
Perner, Anders
Meyhoff, Tine Sylvest
Bukan, Ramin Brandt
Rello, Jordi
Bauer, Philippe R.
van de Louw, Andry
Taccone, Fabio Silvio
Salluh, Jorge
Hemelaar, Pleun
Schellongowski, Peter
Rusinova, Katerina
Terzi, Nicolas
Mehta, Sangeeta
Antonelli, Massimo
Kouatchet, Achille
Klepstad, Pål
Valkonen, Miia
Landburg, Precious Pearl
Barratt-Due, Andreas
Bruneel, Fabrice
Pène, Frédéric
Metaxa, Victoria
Moreau, Anne Sophie
Souppart, Virginie
Burghi, Gaston
Girault, Christophe
Silva, Ulysses V. A.
Montini, Luca
Barbier, Francois
Nielsen, Lene B.
Gaborit, Benjamin
Mokart, Djamel
Chevret, Sylvie
Azoulay, Elie
author_sort Martin-Loeches, Ignacio
collection PubMed
description BACKGROUND: It is unclear whether influenza infection and associated co-infection are associated with patient-important outcomes in critically ill immunocompromised patients with acute respiratory failure. METHODS: Preplanned secondary analysis of EFRAIM, a prospective cohort study of 68 hospitals in 16 countries. We included 1611 patients aged 18 years or older with non-AIDS-related immunocompromise, who were admitted to the ICU with acute hypoxemic respiratory failure. The main exposure of interest was influenza infection status. The primary outcome of interest was all-cause hospital mortality, and secondary outcomes ICU length of stay (LOS) and 90-day mortality. RESULTS: Influenza infection status was categorized into four groups: patients with influenza alone (n = 95, 5.8%), patients with influenza plus pulmonary co-infection (n = 58, 3.6%), patients with non-influenza pulmonary infection (n = 820, 50.9%), and patients without pulmonary infection (n = 638, 39.6%). Influenza infection status was associated with a requirement for intubation and with LOS in ICU (P < 0.001). Patients with influenza plus co-infection had the highest rates of intubation and longest ICU LOS. On crude analysis, influenza infection status was associated with ICU mortality (P < 0.001) but not hospital mortality (P = 0.09). Patients with influenza plus co-infection and patients with non-influenza infection alone had similar ICU mortality (41% and 37% respectively) that was higher than patients with influenza alone or those without infection (33% and 26% respectively). A propensity score-matched analysis did not show a difference in hospital mortality attributable to influenza infection (OR = 1.01, 95%CI 0.90–1.13, P = 0.85). Age, severity scores, ARDS, and performance status were all associated with ICU, hospital, and 90-day mortality. CONCLUSIONS: Category of infectious etiology of respiratory failure (influenza, non-influenza, influenza plus co-infection, and non-infectious) was associated with ICU but not hospital mortality. In a propensity score-matched analysis, influenza infection was not associated with the primary outcome of hospital mortality. Overall, influenza infection alone may not be an independent risk factor for hospital mortality in immunosuppressed patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-019-2425-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6498695
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64986952019-05-09 Influenza and associated co-infections in critically ill immunosuppressed patients Martin-Loeches, Ignacio Lemiale, Virginie Geoghegan, Pierce McMahon, Mary Aisling Pickkers, Peter Soares, Marcio Perner, Anders Meyhoff, Tine Sylvest Bukan, Ramin Brandt Rello, Jordi Bauer, Philippe R. van de Louw, Andry Taccone, Fabio Silvio Salluh, Jorge Hemelaar, Pleun Schellongowski, Peter Rusinova, Katerina Terzi, Nicolas Mehta, Sangeeta Antonelli, Massimo Kouatchet, Achille Klepstad, Pål Valkonen, Miia Landburg, Precious Pearl Barratt-Due, Andreas Bruneel, Fabrice Pène, Frédéric Metaxa, Victoria Moreau, Anne Sophie Souppart, Virginie Burghi, Gaston Girault, Christophe Silva, Ulysses V. A. Montini, Luca Barbier, Francois Nielsen, Lene B. Gaborit, Benjamin Mokart, Djamel Chevret, Sylvie Azoulay, Elie Crit Care Research BACKGROUND: It is unclear whether influenza infection and associated co-infection are associated with patient-important outcomes in critically ill immunocompromised patients with acute respiratory failure. METHODS: Preplanned secondary analysis of EFRAIM, a prospective cohort study of 68 hospitals in 16 countries. We included 1611 patients aged 18 years or older with non-AIDS-related immunocompromise, who were admitted to the ICU with acute hypoxemic respiratory failure. The main exposure of interest was influenza infection status. The primary outcome of interest was all-cause hospital mortality, and secondary outcomes ICU length of stay (LOS) and 90-day mortality. RESULTS: Influenza infection status was categorized into four groups: patients with influenza alone (n = 95, 5.8%), patients with influenza plus pulmonary co-infection (n = 58, 3.6%), patients with non-influenza pulmonary infection (n = 820, 50.9%), and patients without pulmonary infection (n = 638, 39.6%). Influenza infection status was associated with a requirement for intubation and with LOS in ICU (P < 0.001). Patients with influenza plus co-infection had the highest rates of intubation and longest ICU LOS. On crude analysis, influenza infection status was associated with ICU mortality (P < 0.001) but not hospital mortality (P = 0.09). Patients with influenza plus co-infection and patients with non-influenza infection alone had similar ICU mortality (41% and 37% respectively) that was higher than patients with influenza alone or those without infection (33% and 26% respectively). A propensity score-matched analysis did not show a difference in hospital mortality attributable to influenza infection (OR = 1.01, 95%CI 0.90–1.13, P = 0.85). Age, severity scores, ARDS, and performance status were all associated with ICU, hospital, and 90-day mortality. CONCLUSIONS: Category of infectious etiology of respiratory failure (influenza, non-influenza, influenza plus co-infection, and non-infectious) was associated with ICU but not hospital mortality. In a propensity score-matched analysis, influenza infection was not associated with the primary outcome of hospital mortality. Overall, influenza infection alone may not be an independent risk factor for hospital mortality in immunosuppressed patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-019-2425-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-02 /pmc/articles/PMC6498695/ /pubmed/31046842 http://dx.doi.org/10.1186/s13054-019-2425-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Martin-Loeches, Ignacio
Lemiale, Virginie
Geoghegan, Pierce
McMahon, Mary Aisling
Pickkers, Peter
Soares, Marcio
Perner, Anders
Meyhoff, Tine Sylvest
Bukan, Ramin Brandt
Rello, Jordi
Bauer, Philippe R.
van de Louw, Andry
Taccone, Fabio Silvio
Salluh, Jorge
Hemelaar, Pleun
Schellongowski, Peter
Rusinova, Katerina
Terzi, Nicolas
Mehta, Sangeeta
Antonelli, Massimo
Kouatchet, Achille
Klepstad, Pål
Valkonen, Miia
Landburg, Precious Pearl
Barratt-Due, Andreas
Bruneel, Fabrice
Pène, Frédéric
Metaxa, Victoria
Moreau, Anne Sophie
Souppart, Virginie
Burghi, Gaston
Girault, Christophe
Silva, Ulysses V. A.
Montini, Luca
Barbier, Francois
Nielsen, Lene B.
Gaborit, Benjamin
Mokart, Djamel
Chevret, Sylvie
Azoulay, Elie
Influenza and associated co-infections in critically ill immunosuppressed patients
title Influenza and associated co-infections in critically ill immunosuppressed patients
title_full Influenza and associated co-infections in critically ill immunosuppressed patients
title_fullStr Influenza and associated co-infections in critically ill immunosuppressed patients
title_full_unstemmed Influenza and associated co-infections in critically ill immunosuppressed patients
title_short Influenza and associated co-infections in critically ill immunosuppressed patients
title_sort influenza and associated co-infections in critically ill immunosuppressed patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498695/
https://www.ncbi.nlm.nih.gov/pubmed/31046842
http://dx.doi.org/10.1186/s13054-019-2425-6
work_keys_str_mv AT martinloechesignacio influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT lemialevirginie influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT geogheganpierce influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT mcmahonmaryaisling influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT pickkerspeter influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT soaresmarcio influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT perneranders influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT meyhofftinesylvest influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT bukanraminbrandt influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT rellojordi influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT bauerphilipper influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT vandelouwandry influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT tacconefabiosilvio influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT salluhjorge influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT hemelaarpleun influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT schellongowskipeter influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT rusinovakaterina influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT terzinicolas influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT mehtasangeeta influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT antonellimassimo influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT kouatchetachille influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT klepstadpal influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT valkonenmiia influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT landburgpreciouspearl influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT barrattdueandreas influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT bruneelfabrice influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT penefrederic influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT metaxavictoria influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT moreauannesophie influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT souppartvirginie influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT burghigaston influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT giraultchristophe influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT silvaulyssesva influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT montiniluca influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT barbierfrancois influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT nielsenleneb influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT gaboritbenjamin influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT mokartdjamel influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT chevretsylvie influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT azoulayelie influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients
AT influenzaandassociatedcoinfectionsincriticallyillimmunosuppressedpatients